USP5 and pancreatic neoplasm: Ubiquitin-specific peptidase 5 (USP5) correlates with serum CEA and CA19-9 levels in pancreatic cancer patients, and high USP5 expression is an unfavorable prognostic factor for pancreatic cancer.